 | • レポートコード：GIR-105X01064 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗糖尿病薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗糖尿病薬の種類別市場規模（経口薬、注射薬）、用途別市場規模（1型糖尿病、2型糖尿病、妊娠糖尿病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗糖尿病薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly、Novartis、Boehringer Ingelheim、Merck、Novo Nordisk、Sanofi、AstraZeneca、Takeda、Bayer、Pfizer ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口薬、注射薬 ・用途別分析2016年-2026年：1型糖尿病、2型糖尿病、妊娠糖尿病、その他 ・抗糖尿病薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗糖尿病薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗糖尿病薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗糖尿病薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗糖尿病薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Antidiabetic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Antidiabetic Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Antidiabetic Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Antidiabetic Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral Drugs
Injectable Drugs
Market segment by Application can be divided into
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes Mellitus
Others
The key market players for global Antidiabetic Drugs market are listed below:
Eli Lilly
Novartis
Boehringer Ingelheim
Merck
Novo Nordisk
Sanofi
AstraZeneca
Takeda
Bayer
Pfizer
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Antidiabetic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antidiabetic Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral Drugs
1.2.3 Injectable Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Antidiabetic Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.3.4 Gestational Diabetes Mellitus
1.3.5 Others
1.4 Global Antidiabetic Drugs Market Size & Forecast
1.4.1 Global Antidiabetic Drugs Sales in Value (2016-2026))
1.4.2 Global Antidiabetic Drugs Sales in Volume (2016-2026)
1.4.3 Global Antidiabetic Drugs Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Antidiabetic Drugs Production Capacity Analysis
1.5.1 Global Antidiabetic Drugs Total Production Capacity (2016-2026)
1.5.2 Global Antidiabetic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antidiabetic Drugs Market Drivers
1.6.2 Antidiabetic Drugs Market Restraints
1.6.3 Antidiabetic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Antidiabetic Drugs Product and Services
2.1.4 Eli Lilly Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Antidiabetic Drugs Product and Services
2.2.4 Novartis Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Antidiabetic Drugs Product and Services
2.3.4 Boehringer Ingelheim Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Antidiabetic Drugs Product and Services
2.4.4 Merck Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Novo Nordisk
2.5.1 Novo Nordisk Details
2.5.2 Novo Nordisk Major Business
2.5.3 Novo Nordisk Antidiabetic Drugs Product and Services
2.5.4 Novo Nordisk Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Antidiabetic Drugs Product and Services
2.6.4 Sanofi Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Antidiabetic Drugs Product and Services
2.7.4 AstraZeneca Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Takeda
2.8.1 Takeda Details
2.8.2 Takeda Major Business
2.8.3 Takeda Antidiabetic Drugs Product and Services
2.8.4 Takeda Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Antidiabetic Drugs Product and Services
2.9.4 Bayer Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Antidiabetic Drugs Product and Services
2.10.4 Pfizer Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Antidiabetic Drugs Sales by Manufacturer
3.1 Global Antidiabetic Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Antidiabetic Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Antidiabetic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Antidiabetic Drugs Manufacturer Market Share
3.4.2 Top 6 Antidiabetic Drugs Manufacturer Market Share
3.5 Global Antidiabetic Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Antidiabetic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antidiabetic Drugs Market Size by Region
4.1.1 Global Antidiabetic Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Antidiabetic Drugs Revenue by Region (2016-2026)
4.2 North America Antidiabetic Drugs Revenue (2016-2026)
4.3 Europe Antidiabetic Drugs Revenue (2016-2026)
4.4 Asia-Pacific Antidiabetic Drugs Revenue (2016-2026)
4.5 South America Antidiabetic Drugs Revenue (2016-2026)
4.6 Middle East and Africa Antidiabetic Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Antidiabetic Drugs Sales in Volume by Type (2016-2026)
5.2 Global Antidiabetic Drugs Revenue by Type (2016-2026)
5.3 Global Antidiabetic Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Antidiabetic Drugs Sales in Volume by Application (2016-2026)
6.2 Global Antidiabetic Drugs Revenue by Application (2016-2026)
6.3 Global Antidiabetic Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Antidiabetic Drugs Sales by Type (2016-2026)
7.2 North America Antidiabetic Drugs Sales by Application (2016-2026)
7.3 North America Antidiabetic Drugs Market Size by Country
7.3.1 North America Antidiabetic Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Antidiabetic Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Antidiabetic Drugs Sales by Type (2016-2026)
8.2 Europe Antidiabetic Drugs Sales by Application (2016-2026)
8.3 Europe Antidiabetic Drugs Market Size by Country
8.3.1 Europe Antidiabetic Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Antidiabetic Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Antidiabetic Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Antidiabetic Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Antidiabetic Drugs Market Size by Region
9.3.1 Asia-Pacific Antidiabetic Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Antidiabetic Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Antidiabetic Drugs Sales by Type (2016-2026)
10.2 South America Antidiabetic Drugs Sales by Application (2016-2026)
10.3 South America Antidiabetic Drugs Market Size by Country
10.3.1 South America Antidiabetic Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Antidiabetic Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antidiabetic Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Antidiabetic Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Antidiabetic Drugs Market Size by Country
11.3.1 Middle East & Africa Antidiabetic Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Antidiabetic Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Antidiabetic Drugs Typical Distributors
12.3 Antidiabetic Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Antidiabetic Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Antidiabetic Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly Major Business
Table 5. Eli Lilly Antidiabetic Drugs Product and Services
Table 6. Eli Lilly Antidiabetic Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Antidiabetic Drugs Product and Services
Table 10. Novartis Antidiabetic Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim Major Business
Table 13. Boehringer Ingelheim Antidiabetic Drugs Product and Services
Table 14. Boehringer Ingelheim Antidiabetic Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Antidiabetic Drugs Product and Services
Table 18. Merck Antidiabetic Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 20. Novo Nordisk Major Business
Table 21. Novo Nordisk Antidiabetic Drugs Product and Services
Table 22. Novo Nordisk Antidiabetic Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Antidiabetic Drugs Product and Services
Table 26. Sanofi Antidiabetic Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 28. AstraZeneca Major Business
Table 29. AstraZeneca Antidiabetic Drugs Product and Services
Table 30. AstraZeneca Antidiabetic Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Takeda Basic Information, Manufacturing Base and Competitors
Table 32. Takeda Major Business
Table 33. Takeda Antidiabetic Drugs Product and Services
Table 34. Takeda Antidiabetic Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Bayer Basic Information, Manufacturing Base and Competitors
Table 36. Bayer Major Business
Table 37. Bayer Antidiabetic Drugs Product and Services
Table 38. Bayer Antidiabetic Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Pfizer Basic Information, Manufacturing Base and Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer Antidiabetic Drugs Product and Services
Table 42. Pfizer Antidiabetic Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Antidiabetic Drugs Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 44. Global Antidiabetic Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Antidiabetic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Antidiabetic Drugs Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 47. Head Office and Antidiabetic Drugs Production Site of Key Manufacturer
Table 48. Global Antidiabetic Drugs Sales by Region (2016-2021e) & (K Pcs)
Table 49. Global Antidiabetic Drugs Sales by Region (2021-2026) & (K Pcs)
Table 50. Global Antidiabetic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Antidiabetic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Antidiabetic Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 53. Global Antidiabetic Drugs Sales by Type (2021-2026) & (K Pcs)
Table 54. Global Antidiabetic Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Antidiabetic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Antidiabetic Drugs Price by Type (2016-2021e) & (USD/Pcs)
Table 57. Global Antidiabetic Drugs Price by Type (2021-2026) & (USD/Pcs)
Table 58. Global Antidiabetic Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 59. Global Antidiabetic Drugs Sales by Application (2021-2026) & (K Pcs)
Table 60. Global Antidiabetic Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Antidiabetic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Antidiabetic Drugs Price by Application (2016-2021e) & (USD/Pcs)
Table 63. Global Antidiabetic Drugs Price by Application (2021-2026) & (USD/Pcs)
Table 64. North America Antidiabetic Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 65. North America Antidiabetic Drugs Sales by Country (2021-2026) & (K Pcs)
Table 66. North America Antidiabetic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Antidiabetic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Antidiabetic Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 69. North America Antidiabetic Drugs Sales by Type (2021-2026) & (K Pcs)
Table 70. North America Antidiabetic Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 71. North America Antidiabetic Drugs Sales by Application (2021-2026) & (K Pcs)
Table 72. Europe Antidiabetic Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 73. Europe Antidiabetic Drugs Sales by Country (2021-2026) & (K Pcs)
Table 74. Europe Antidiabetic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Antidiabetic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Antidiabetic Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 77. Europe Antidiabetic Drugs Sales by Type (2021-2026) & (K Pcs)
Table 78. Europe Antidiabetic Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 79. Europe Antidiabetic Drugs Sales by Application (2021-2026) & (K Pcs)
Table 80. Asia-Pacific Antidiabetic Drugs Sales by Region (2016-2021e) & (K Pcs)
Table 81. Asia-Pacific Antidiabetic Drugs Sales by Region (2021-2026) & (K Pcs)
Table 82. Asia-Pacific Antidiabetic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Antidiabetic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Antidiabetic Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 85. Asia-Pacific Antidiabetic Drugs Sales by Type (2021-2026) & (K Pcs)
Table 86. Asia-Pacific Antidiabetic Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 87. Asia-Pacific Antidiabetic Drugs Sales by Application (2021-2026) & (K Pcs)
Table 88. South America Antidiabetic Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 89. South America Antidiabetic Drugs Sales by Country (2021-2026) & (K Pcs)
Table 90. South America Antidiabetic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Antidiabetic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Antidiabetic Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 93. South America Antidiabetic Drugs Sales by Type (2021-2026) & (K Pcs)
Table 94. South America Antidiabetic Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 95. South America Antidiabetic Drugs Sales by Application (2021-2026) & (K Pcs)
Table 96. Middle East & Africa Antidiabetic Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 97. Middle East & Africa Antidiabetic Drugs Sales by Country (2021-2026) & (K Pcs)
Table 98. Middle East & Africa Antidiabetic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Antidiabetic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Antidiabetic Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 101. Middle East & Africa Antidiabetic Drugs Sales by Type (2021-2026) & (K Pcs)
Table 102. Middle East & Africa Antidiabetic Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 103. Middle East & Africa Antidiabetic Drugs Sales by Application (2021-2026) & (K Pcs)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Antidiabetic Drugs Typical Distributors
Table 107. Antidiabetic Drugs Typical Customers
List of Figures
Figure 1. Antidiabetic Drugs Picture
Figure 2. Global Antidiabetic Drugs Sales Market Share by Type in 2020
Figure 3. Oral Drugs
Figure 4. Injectable Drugs
Figure 5. Global Antidiabetic Drugs Sales Market Share by Application in 2020
Figure 6. Type 1 Diabetes
Figure 7. Type 2 Diabetes
Figure 8. Gestational Diabetes Mellitus
Figure 9. Others
Figure 10. Global Antidiabetic Drugs Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 11. Global Antidiabetic Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Antidiabetic Drugs Sales (2016-2026) & (K Pcs)
Figure 32. Global Antidiabetic Drugs Production Capacity (2016-2026) & (K Pcs)
Figure 33. Global Antidiabetic Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Antidiabetic Drugs Market Drivers
Figure 35. Antidiabetic Drugs Market Restraints
Figure 36. Antidiabetic Drugs Market Trends
Figure 37. Global Antidiabetic Drugs Sales Market Share by Manufacturer in 2020
Figure 38. Global Antidiabetic Drugs Revenue Market Share by Manufacturer in 2020
Figure 39. Antidiabetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Antidiabetic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Antidiabetic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Antidiabetic Drugs Sales Market Share by Region (2016-2026)
Figure 43. Global Antidiabetic Drugs Revenue Market Share by Region (2016-2026)
Figure 44. North America Antidiabetic Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Europe Antidiabetic Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Antidiabetic Drugs Revenue (2016-2026) & (USD Million)
Figure 47. South America Antidiabetic Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Antidiabetic Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Global Antidiabetic Drugs Sales Market Share by Type (2016-2026)
Figure 50. Global Antidiabetic Drugs Revenue Market Share by Type (2016-2026)
Figure 51. Global Antidiabetic Drugs Price by Type (2016-2026) & (USD/Pcs)
Figure 52. Global Antidiabetic Drugs Sales Market Share by Application (2016-2026)
Figure 53. Global Antidiabetic Drugs Revenue Market Share by Application (2016-2026)
Figure 54. Global Antidiabetic Drugs Price by Application (2016-2026) & (USD/Pcs)
Figure 55. North America Antidiabetic Drugs Sales Market Share by Country (2016-2026)
Figure 56. North America Antidiabetic Drugs Revenue Market Share by Country (2016-2026)
Figure 57. North America Antidiabetic Drugs Sales Market Share by Type (2016-2026)
Figure 58. North America Antidiabetic Drugs Sales Market Share by Application (2016-2026)
Figure 59. Europe Antidiabetic Drugs Sales Market Share by Country (2016-2026)
Figure 60. Europe Antidiabetic Drugs Revenue Market Share by Country (2016-2026)
Figure 61. Europe Antidiabetic Drugs Sales Market Share by Type (2016-2026)
Figure 62. Europe Antidiabetic Drugs Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Antidiabetic Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Antidiabetic Drugs Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Antidiabetic Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Antidiabetic Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Antidiabetic Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America Antidiabetic Drugs Revenue Market Share by Country (2016-2026)
Figure 69. South America Antidiabetic Drugs Sales Market Share by Type (2016-2026)
Figure 70. South America Antidiabetic Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Antidiabetic Drugs Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Antidiabetic Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Antidiabetic Drugs Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Antidiabetic Drugs Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
経口抗糖尿病（OAD）治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabet…- 世界の経口避妊薬市場 2021：企業別、地域別、種類・用途別 The Oral Contraceptive Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界のエポプロステノールナトリウム薬品市場 2021：企業別、地域別、種類・用途別 The Epoprostenol Sodium Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- メトトレキサート薬口径薬の世界市場2018-2025 Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortions.In 2018, the global Methotrexate Oral Solution Drugs market size was xx million US$ and is forec…
- メルカプトプリン経口液剤の世界市場2018-2025 Mercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases adenine and hypoxanthine. In 2018, the global Mercaptopurine Oral Solution Drugs market size was xx million US$ and is forecast to xx million US in 202…